DE3782276T2 - Interleukin-2 induziertes antineoplastisches peptid. - Google Patents

Interleukin-2 induziertes antineoplastisches peptid.

Info

Publication number
DE3782276T2
DE3782276T2 DE8787304883T DE3782276T DE3782276T2 DE 3782276 T2 DE3782276 T2 DE 3782276T2 DE 8787304883 T DE8787304883 T DE 8787304883T DE 3782276 T DE3782276 T DE 3782276T DE 3782276 T2 DE3782276 T2 DE 3782276T2
Authority
DE
Germany
Prior art keywords
cells
composition
lymphokine
acetonitrile
determined
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787304883T
Other languages
German (de)
English (en)
Other versions
DE3782276D1 (de
Inventor
Ingegerd Hellstrom
Karl Eric Hellstrom
Daniel R Twardzik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Application granted granted Critical
Publication of DE3782276D1 publication Critical patent/DE3782276D1/de
Publication of DE3782276T2 publication Critical patent/DE3782276T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4718—Cytokine-induced proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8787304883T 1986-06-04 1987-06-03 Interleukin-2 induziertes antineoplastisches peptid. Expired - Fee Related DE3782276T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87044086A 1986-06-04 1986-06-04

Publications (2)

Publication Number Publication Date
DE3782276D1 DE3782276D1 (de) 1992-11-26
DE3782276T2 true DE3782276T2 (de) 1993-03-04

Family

ID=25355375

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787304883T Expired - Fee Related DE3782276T2 (de) 1986-06-04 1987-06-03 Interleukin-2 induziertes antineoplastisches peptid.

Country Status (9)

Country Link
EP (1) EP0248642B1 (enExample)
JP (1) JPS6322100A (enExample)
AT (1) ATE81591T1 (enExample)
AU (1) AU612575B2 (enExample)
CA (1) CA1320906C (enExample)
DE (1) DE3782276T2 (enExample)
ES (1) ES2052562T3 (enExample)
GR (1) GR3006212T3 (enExample)
IL (1) IL82734A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196958B (it) * 1986-07-10 1988-11-25 Ellem Ind Farmaceutica Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor
JP7268039B2 (ja) 2018-02-01 2023-05-02 エヌケーマックス カンパニー リミテッド がん治療のためのナチュラルキラー細胞および組成物の製造方法

Also Published As

Publication number Publication date
GR3006212T3 (enExample) 1993-06-21
ES2052562T3 (es) 1994-07-16
EP0248642A3 (en) 1989-11-02
EP0248642A2 (en) 1987-12-09
ATE81591T1 (de) 1992-11-15
AU7378087A (en) 1987-12-10
AU612575B2 (en) 1991-07-18
JPS6322100A (ja) 1988-01-29
DE3782276D1 (de) 1992-11-26
CA1320906C (en) 1993-08-03
IL82734A0 (en) 1987-12-20
EP0248642B1 (en) 1992-10-21
IL82734A (en) 1992-05-25

Similar Documents

Publication Publication Date Title
Maciag et al. High and low molecular weight forms of endothelial cell growth factor.
EP0209061B1 (de) Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
DE3100974C2 (enExample)
DE3650088T2 (de) Inhibin und dessen reinigung.
DE68923401T2 (de) Peptide mit T-Zellen-Helfer-Wirksamkeit.
DE69905368T2 (de) Oxydiertes thymosin beta 4
DE3750106T2 (de) Rekombinanter B-Zell-Differenzierungsfaktor.
EP0159276A2 (en) Substantially purified tumor growth inhibitory factor (tif)
CH653347A5 (de) Verfahren zur reinigung von proteinen.
DE68922202T2 (de) Ein neues Thrombomodulin ähnliches Glykoprotein erhältlich aus Harn.
DE69232698T2 (de) Neuer megakaryocyten-verstärker
DE3028919A1 (de) Homogenes fibroblasten-interferon und dessen herstellung
DE69230879T2 (de) Verwendung von Hepatocyten-Wachstumsfaktoren zur Herstellung eines Vermehrungssystems für Hematopoietische Stammzellen
DE68917826T2 (de) Rekombinantes, unglycosiliertes Human-IL2 in reduzierter Form, Herstellungsprozess und medizinische Anwendung.
DE3782276T2 (de) Interleukin-2 induziertes antineoplastisches peptid.
DE68907941T2 (de) Polypeptide mit Zellausdehnungs-Aktivität.
Rosen et al. Human placenta contains an epithelial scatter protein
DE3515336C2 (de) Verfahren zur Herstellung und Reinigung von â-Interferon
DE69112573T2 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
EP0250000B1 (de) Neue Polypeptide, ihre Herstellung und ihre Verwendung
DE3643428C2 (enExample)
DE69229202T2 (de) Verfahren zur reinigung von menschlichem bcdf
DE3421731A1 (de) Humaner-tumor-nekrose-faktor
DE68927009T2 (de) EXPRESSION UND PROZESSIERUNG VON ACETYLIERTEN FGFs IN HEFEN
DE69202136T2 (de) Neuartiges calcitonin, und seine herstellung und verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee